Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aberrant Signaling Pathways in Glioma
Mitsutoshi Nakada, Daisuke Kita, Takuya Watanabe, et al.
Cancers (2011) Vol. 3, Iss. 3, pp. 3242-3278
Open Access | Times Cited: 246

Showing 1-25 of 246 citing articles:

Glioblastoma Multiforme: A Review of its Epidemiology and Pathogenesis through Clinical Presentation and Treatment
Farina Hanif, Kanza Muzaffar, Kahkashan Perveen, et al.
PubMed (2017) Vol. 18, Iss. 1, pp. 3-9
Closed Access | Times Cited: 1065
Targeting cellular pathways in glioblastoma multiforme
Joshua R. D. Pearson, Tarik Regad
Signal Transduction and Targeted Therapy (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 307
Diagnostic and Therapeutic Biomarkers in Glioblastoma: Current Status and Future Perspectives
Wojciech Szopa, Thomas A. Burley, Gabriela Kramer‐Marek, et al.
BioMed Research International (2017) Vol. 2017, pp. 1-13
Open Access | Times Cited: 292
The biology and mathematical modelling of glioma invasion: a review
Juan Carlos López Alfonso, Katrin Talkenberger, Michael Seifert, et al.
Journal of The Royal Society Interface (2017) Vol. 14, Iss. 136, pp. 20170490-20170490
Open Access | Times Cited: 195
Molecular and Genomic Alterations in Glioblastoma Multiforme
Inês Crespo, Ana Louisa Vital, María González-Tablas, et al.
American Journal Of Pathology (2015) Vol. 185, Iss. 7, pp. 1820-1833
Open Access | Times Cited: 191
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
Jin‐Ku Lee, Zhaoqi Liu, K. Jason, et al.
Nature Genetics (2018) Vol. 50, Iss. 10, pp. 1399-1411
Open Access | Times Cited: 174
Current Understanding on EGFR and Wnt/ -Catenin Signaling in Glioma and Their Possible Crosstalk
Indranil Paul, Sukanta S. Bhattacharya, Anirban Chatterjee, et al.
Genes & Cancer (2013) Vol. 4, Iss. 11-12, pp. 427-446
Open Access | Times Cited: 142
Theranostic 3-Dimensional nano brain-implant for prolonged and localized treatment of recurrent glioma
Ranjith K. Ramachandran, Vijayabhaskarreddy Junnuthula, Genekehal Siddaramana Gowd, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 121
Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
Faiqa Mudassar, Han Shen, Geraldine M. O’Neill, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 113
LncRNA-XIST interacts with miR-29c to modulate the chemoresistance of glioma cell to TMZ through DNA mismatch repair pathway
Peng Du, Haiting Zhao, Renjun Peng, et al.
Bioscience Reports (2017) Vol. 37, Iss. 5
Open Access | Times Cited: 110
Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I–III
Michela Visani, Dario de Biase, Gianluca Marucci, et al.
Molecular Oncology (2013) Vol. 8, Iss. 2, pp. 417-430
Open Access | Times Cited: 105
Anticancer Mechanism of Curcumin on Human Glioblastoma
Shu Chyi Wong, Muhamad Noor Alfarizal Kamarudin, Rakesh Naidu
Nutrients (2021) Vol. 13, Iss. 3, pp. 950-950
Open Access | Times Cited: 87
Current Approaches for Glioma Gene Therapy and Virotherapy
Kaushik Banerjee, Felipe J. Núñez, Santiago Haase, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 75
Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions
Tianzhong Li, Jingfeng Li, Zhi Chen, et al.
Journal of Controlled Release (2022) Vol. 352, pp. 338-370
Closed Access | Times Cited: 67
The Immune Profile of Major Dysmood Disorder: Proof of Concept and Mechanism Using the Precision Nomothetic Psychiatry Approach
Michael Maes, Muanpetch Rachayon, Ketsupar Jirakran, et al.
Cells (2022) Vol. 11, Iss. 7, pp. 1183-1183
Open Access | Times Cited: 65
Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy
Falko Lange, Max Frederik Hörnschemeyer, Timo Kirschstein
Cells (2021) Vol. 10, Iss. 5, pp. 1226-1226
Open Access | Times Cited: 60
Adverse Childhood Experiences Predict the Phenome of Affective Disorders and These Effects Are Mediated by Staging, Neuroimmunotoxic and Growth Factor Profiles
Michael Maes, Muanpetch Rachayon, Ketsupar Jirakran, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1564-1564
Open Access | Times Cited: 53
Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms
Raziyeh Salami, Marziyeh Salami, Alireza Mafi, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 43
Glioblastoma, from disease understanding towards optimal cell-based in vitro models
Chiara Boccellato, Markus Rehm
Cellular Oncology (2022) Vol. 45, Iss. 4, pp. 527-541
Open Access | Times Cited: 39
Regulated cell death in glioma: promising targets for natural small-molecule compounds
Mingyu Han, Sui Li, Huali Fan, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 9
Radiogenomics and machine learning predict oncogenic signaling pathways in glioblastoma
Abdul Basit Ahanger, Syed Wajid Aalam, Tariq Masoodi, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
Carla Lucia Esposito, Silvia Nuzzo, Silvia Catuogno, et al.
Molecular Therapy — Nucleic Acids (2017) Vol. 10, pp. 398-411
Open Access | Times Cited: 83
mTOR-Dependent Cell Proliferation in the Brain
Larisa Ryskalin, Gloria Lazzeri, Marina Flaibani, et al.
BioMed Research International (2017) Vol. 2017, pp. 1-14
Open Access | Times Cited: 78
Prospective of curcumin, a pleiotropic signalling molecule from Curcuma longa in the treatment of Glioblastoma
Pratibha Mehta Luthra, Neetika Lal
European Journal of Medicinal Chemistry (2015) Vol. 109, pp. 23-35
Closed Access | Times Cited: 70
Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres
Rajesh Mukthavaram, Xiao Ouyang, Rohit Saklecha, et al.
Journal of Translational Medicine (2015) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Page 1 - Next Page

Scroll to top